CDSCO License for Foetal acoustic stimulator
Medical Device Information
Intended Use
Uses sound stimuli to assess foetal well-being. This device is used to evaluate the status of the foetus as expressed by, e.g., foetal heart rate changes or foetal acid-base status, in antepartum tests and/or during intrapartum monitoring.

Comprehensive Guide to CDSCO Licensing for Foetal Acoustic Stimulator (Class B Medical Device)
As seasoned regulatory consultants with over 25 years of experience and having assisted 500+ companies successfully obtain CDSCO licenses, we understand the critical steps and nuances involved in registering medical devices in India. This detailed guide focuses on the Foetal Acoustic Stimulator, a Class B obstetrical and gynecological device designed to assess foetal well-being using sound stimuli. Understanding the regulatory framework and practical requirements is vital for manufacturers and importers aiming to enter the Indian market efficiently.
Introduction to Foetal Acoustic Stimulator and Regulatory Importance
A Foetal Acoustic Stimulator is an essential diagnostic device used to evaluate the foetus's status by monitoring heart rate changes or acid-base status during antepartum and intrapartum periods. Given its direct impact on maternal and foetal health, the device is classified under Class B risk category by CDSCO, requiring strict compliance with regulatory norms to ensure safety and efficacy.
Obtaining the appropriate CDSCO license not only ensures market access but also builds trust among healthcare providers and patients, reflecting adherence to Indian medical device regulations.
CDSCO Regulatory Framework for Foetal Acoustic Stimulator
The Central Drugs Standard Control Organization (CDSCO) regulates medical devices in India under the Medical Device Rules (MDR) 2017. For a Class B device like the Foetal Acoustic Stimulator, the regulatory pathway involves obtaining a Manufacturing License (MD5) from the State Licensing Authority.
The entire licensing lifecycle includes:
- Test License (MD13) for product testing
- Product testing in government-approved labs
- Document preparation and submission
- Audit by notified bodies
- Resolution of queries
- Final grant of license (MD5)
For detailed classification, visit our Medical Device Classification guide.
Risk Classification and License Requirements for Foetal Acoustic Stimulator
The Foetal Acoustic Stimulator falls under Class B, which denotes low to moderate risk devices. This classification necessitates:
- MD5 Manufacturing License (Application Form MD3) from the State Licensing Authority
- Compliance with quality management system requirements
- Product testing and audit by a notified body
Manufacturers must adhere to the regulatory timelines and documentation requirements outlined in the MDR.
Manufacturing License Process for Class B Devices (MD5 License)
The MD5 license process is structured but involves multiple sequential steps:
Apply for Test License (MD13): Before manufacturing, obtain a test license to produce samples for testing. This usually takes 1.5 to 2 months.
Product Testing: Conduct testing at CDSCO-approved laboratories to ensure compliance with essential principles.
Document Preparation: Compile all required technical and quality documents.
Submit MD5 Application: File Form MD3 for MD5 license via the CDSCO MD Online Portal.
Audit by Notified Body: The notified body conducts a thorough audit of manufacturing facilities and QMS.
Resolve Queries: Address any observations raised during audit or by CDSCO.
License Grant: Upon satisfactory compliance, the State Licensing Authority issues the MD5 license.
For detailed guidance, refer to our MD5 License Guide.
Manufacturing License Documents Required for Foetal Acoustic Stimulator
Accurate and complete documentation is critical. The following are mandatory:
- Company Constitution: Memorandum of Association, Articles of Association, or Partnership Deed
- Proof of Premises Ownership or Lease Agreement
- Technical Staff Qualification and Experience Certificates
- Fire NOC and Pollution Control NOC
- Device Master File (DMF): Detailed product specifications, design, manufacturing processes (Guide here)
- Plant Master File (PMF): Description of manufacturing facilities and quality systems (Guide here)
- Essential Principles Checklist: Demonstrating compliance with safety and performance requirements
- Risk Management File: Documenting risk analysis and mitigation strategies (Risk Management Insights)
- Test Reports: From CDSCO-approved testing laboratories (Approved Labs List)
- Labels and Instructions for Use (IFU)
- Quality Management System Documents: ISO 13485 certification and related SOPs
Import License Process for Foetal Acoustic Stimulator (MD15 License)
If you are an importer intending to bring the Foetal Acoustic Stimulator into India, you must obtain an MD15 Import License from CDSCO Central Licensing Authority.
Key steps include:
Document Preparation: Gather all necessary import-related certificates and documentation.
Application Submission: File Form MD14 on the CDSCO MD Online Portal.
Query Resolution: Address any queries raised by CDSCO.
License Issuance: Upon approval, the MD15 license is granted.
Refer to our detailed Import License Guide for comprehensive support.
Import License Documents Required
- Valid Manufacturing License issued by the country of origin
- Free Sale Certificate
- ISO 13485:2016 Certification
- CE Certificate or equivalent
- Device Master File and Plant Master File
- Wholesale license
- Company Constitution documents
Timeline and Processing Duration
- MD13 Test License: Approximately 1.5 to 2 months
- Product Testing: 2 to 3 weeks (may vary by lab workload)
- MD5 Manufacturing License: 3 to 4 months total (including audit and query resolution)
Overall, for a Class B Foetal Acoustic Stimulator, expect the entire manufacturing license process to take around 4 to 5 months from start to finish.
Government Fees and Costs
- Test License (MD13): Typically nominal, included in overall process
- MD5 License Application Fee: Rs. 5,000 per application
- Product Fee: Rs. 500 per product
- Audit and Testing Costs: Vary depending on notified body and testing labs
For imports:
- Fees depend on device class; Class B usually attracts moderate fees
Common Challenges and Solutions
- Delayed Testing: Schedule testing early and confirm availability with notified labs.
- Incomplete Documentation: Utilize checklists and expert reviews to avoid rejection.
- Audit Non-Compliance: Conduct pre-audit assessments and train staff thoroughly.
- Query Delays: Respond promptly and comprehensively to CDSCO queries.
Expert Consultation and Support
With our extensive experience, we provide tailored consulting to streamline your CDSCO licensing journey. From document preparation to audit readiness and query management, our expert team ensures your Foetal Acoustic Stimulator meets all regulatory expectations efficiently.
Getting Started with Your CDSCO License Application
Assess Your Device Class and Confirm Requirements: Verify the Class B status and documentation needs.
Prepare Your Device and Plant Master Files: Use our comprehensive guides to compile accurate files.
Apply for Test License (MD13): Initiate sample production for testing.
Schedule Product Testing: Coordinate with CDSCO-approved labs early to avoid delays.
Complete Documentation and Submit MD5 Application: Use the CDSCO MD Online Portal to file your application.
Prepare for Audit: Engage a notified body from the Notified Bodies List and conduct internal audits.
Respond to Queries Promptly: Ensure quick turnaround to maintain timeline.
By following these actionable steps and leveraging our expert insights, manufacturers and importers can confidently navigate the regulatory landscape for the Foetal Acoustic Stimulator and successfully launch their products in the Indian market.